VIVAnews - PT CIMB Securities Indonesia maintains the outperform rating for PT Kalbe Farma Tbk (KLBF) shares with a targeted price of Rp 1,900 per share.
According to the securities company in its research today, Jan 28, KLBF will be benefited from the health insurance scheme. As for the 2010 State Budget, the Indonesian government has allocated Rp 21 trillion to health ministry in which 32 percent of the amount will be used for public health security.
CIMB also signaled that there is neutral impact of tax expense over expenditures and promotion of pharmaceutical companies. In addition, the governmental regulations and the appreciation of Indonesian rupiah will provide positive catalyst for the share.
In the mean time, Kalbe's shares gained Rp 40 (2.77 percent) in today's trading to Rp 1,480.
--
Translated by: Bonardo Maulana Wahono
